ALLMedicine™ Hypopharyngeal Cancer Center

Jan 23rd, 2023 - This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. "Investigational" means that the drug or combin...

Jan 19th, 2023 - The purpose of this study was to investigate the prognostic significance of the preoperative controlling nutritional status (CONUT) score in patients with resectable advanced hypopharyngeal cancer. This retrospective study included 113 advanced hy...

Jan 8th, 2023 - Our study sought to analyze the clinical characteristics and risk factors of central lymph node and thyroid metastasis in patients with hypopharyngeal carcinoma. The current study included a total of 152 patients who suffered from hypopharyngeal c...

Jan 3rd, 2023 - The preoperative controlling nutritional status (pCONUT) score has been shown correlated with the prognosis of some cancerous diseases; however, little is known about the effect of pCONUT score on hypopharyngeal cancer (HPC). Therefore, the object...

Dec 18th, 2022 - To evaluate the diagnostic value of narrow band imaging (NBI) endoscopic classification for hypopharyngeal lesions and to lay the groundwork for practical applications of oxygen-injected laryngoscope for hypopharyngeal carcinoma (HC). A total of 1...

Jan 23rd, 2023 - This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. "Investigational" means that the drug or combin...

Aug 19th, 2021 - The study is a single center phase II trial. The purpose is to investigate both the efficacy and safety of chemotherapy combined with anti-PD-1 antibody Followed by chemoradiotherapy in locoregionally advanced hypopharyngeal cancer.

Apr 3rd, 2020 - To determine if MRI can detect preoperative invasion of cartilage by laryngeal and hypopharyngeal carcinoma, and to compare it to CT imaging and histopathology in excised larynges and/or hypopharynges.

Mar 23rd, 2020 - Patients with head and neck cancer treated with chemoradiation, often develop a treatment associated dysphagia. The common complaint is foods sticking in the pharynx. This study seeks to test the Iowa Oral Performance Instrument (IOPI) in the mana...

Mar 5th, 2020 - This is a phase II, multicenter, open-label, single-arm study, planned to enroll 100 patients with localized hypopharyngeal squamous cell carcinoma who are newly treated and could accept radical treatment. Patients would be treated with toripalima...

Oct 6th, 2021 - Advances made in the field of radiation oncology are allowing patients with cancer to derive greater benefit with fewer toxicities, according to Eric M. Horwitz, MD, FABS, FASTRO, and Stephanie E. Weiss, MD, FASTRO. Many efforts being made at Fox ...

Apr 2nd, 2021 - Transcript:Ezra Cohen, MD: Let’s talk about the implications for testing for that. Are you guys testing for HPV? Viktor Grünwald, MD: We actually don’t. Because, we would do so in a research scenario, of course. For our day-to-day practice, thi...

Dec 5th, 2020 - The bond between bevacizumab and vascular endothelial growth factor. More than 1800 oncology specialists and other healthcare professionals turned out for the annual National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines & Qua...

Dec 5th, 2020 - Each year the National Comprehensive Cancer Network (NCCN) presents the latest updates to its Clinical Practice Guidelines in Oncology, as well as the latest cancer therapies by key opinion leaders. This year’s event, held at The Westin Diplomat i...

Dec 5th, 2020 - Robert L. Ferris, MD, PhD Chief, Division of Head and Neck Surgery, Professor, Otolaryngology and Immunology, Director, Fellowship in Advanced Head and Neck Oncologic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA In...